TY - JOUR
T1 - Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor
AU - Gunera, Jakub
AU - Baker, Jillian G.
AU - Van Hilten, Niek
AU - Rosenbaum, Daniel M.
AU - Kolb, Peter
N1 - Funding Information:
J.G.’s Ph.D. thesis was funded through the LOEWE Centre Synmikro. J.G.B. was funded by an MRC grant MR/M0032X-1. D.M.R. thanks the Welch Foundation (I-1770). P.K. thanks the German research foundation DFG for Heisenberg professorship KO4095/4-1.
Funding Information:
J.G.'s Ph.D. thesis was funded through the LOEWE Centre Synmikro. J.G.B. was funded by an MRC grant MR/M0032X-1. D.M.R. thanks the Welch Foundation (I-1770). P.K. thanks the German research foundation DFG for Heisenberg professorship KO4095/4-1.
Publisher Copyright:
© 2020 American Chemical Society.
PY - 2020/10/8
Y1 - 2020/10/8
N2 - The orexin receptors are peptide-sensing G protein-coupled receptors that are intimately linked with regulation of the sleep/wake cycle. We used a recently solved X-ray structure of the orexin receptor subtype 2 in computational docking calculations with the aim to identify additional ligands with unprecedented chemotypes. We found validated ligands with a high hit rate of 29% out of those tested, none of them showing selectivity with respect to the orexin receptor subtype 1. Furthermore, of the higher-affinity compounds examined, none showed any agonist activity. While novel chemical structures can thus be found, selectivity is a challenge owing to the largely identical binding pockets.
AB - The orexin receptors are peptide-sensing G protein-coupled receptors that are intimately linked with regulation of the sleep/wake cycle. We used a recently solved X-ray structure of the orexin receptor subtype 2 in computational docking calculations with the aim to identify additional ligands with unprecedented chemotypes. We found validated ligands with a high hit rate of 29% out of those tested, none of them showing selectivity with respect to the orexin receptor subtype 1. Furthermore, of the higher-affinity compounds examined, none showed any agonist activity. While novel chemical structures can thus be found, selectivity is a challenge owing to the largely identical binding pockets.
UR - http://www.scopus.com/inward/record.url?scp=85092750254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092750254&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.0c00964
DO - 10.1021/acs.jmedchem.0c00964
M3 - Article
C2 - 32977721
AN - SCOPUS:85092750254
SN - 0022-2623
VL - 63
SP - 11045
EP - 11053
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 19
ER -